Form 4: LivaNova PLC: Chief Legal Officer Michael Hutchinson Reports Stock Transactions

Chief Legal Officer Michael Damon Hutchinson reports acquisition and disposal of LivaNova PLC ordinary shares and derivative securities, including restricted stock units, performance stock units, and stock appreciation rights, as per Section 16(a) filing.

Summary

• Michael Damon Hutchinson, Chief Legal Officer of LivaNova PLC, filed a Form 4 detailing changes in beneficial ownership.
• On March 30, 2025, Hutchinson acquired 2,930 ordinary shares through the vesting of restricted stock units (RSUs) at $0.
• He also disposed of 1,020 ordinary shares to satisfy tax liabilities at a price of $39.13 per share.
• Hutchinson was granted 8,944 restricted stock units (RSUs) that vest in three annual installments starting March 30, 2026.
• He was also granted performance stock units (PSUs) tied to free cash flow (FCF), return on invested capital (ROIC), and total shareholder return (TSR), all vesting on March 30, 2028.
• Additionally, Hutchinson was granted 19,581 stock appreciation rights (SARs) that vest in four annual installments starting March 30, 2026, with an exercise price of $39.13 and expiring on March 30, 2035.
• Following these transactions, Hutchinson directly owns 5,666 ordinary shares, 8,944 RSUs, 17,888 PSUs, and 19,581 SARs.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The transactions are part of a standard compensation package, aligning executive interests with company performance. There are no overtly negative signals.

Positives

• The granting of RSUs, PSUs, and SARs aligns Hutchinson's interests with the long-term performance of LivaNova PLC.
• The vesting of RSUs indicates continued service and commitment to the company.

Negatives

• The disposal of shares to cover tax liabilities, while common, slightly reduces Hutchinson's direct shareholding.

Risks

• The vesting of PSUs is contingent on the company's performance related to FCF, ROIC, and TSR, which may not be achieved.
• The SARs' value depends on the future appreciation of LivaNova PLC's stock price above the exercise price of $39.13.

Future Outlook

The document outlines future vesting dates for RSUs, PSUs, and SARs, contingent on continued service and/or company performance metrics (FCF, ROIC, TSR) over the coming years.

Industry Context

Executive compensation through equity grants is a common practice in publicly traded companies to align management's interests with those of shareholders. The specific metrics used for performance-based grants (FCF, ROIC, TSR) reflect the company's strategic priorities.

Comparison to Industry Standards

• Equity compensation packages, including RSUs, PSUs, and SARs, are standard practice among publicly traded companies, particularly in the healthcare and medical device industries where LivaNova operates.
• Companies like Medtronic, Boston Scientific, and Abbott also utilize similar equity-based compensation plans to incentivize their executives.
• The vesting schedules and performance metrics (FCF, ROIC, TSR) are typical benchmarks used to align executive compensation with shareholder value creation.
• The specific amounts and terms of the grants would need to be compared against peer companies to determine if they are above, below, or in line with industry averages.

Stakeholder Impact

• The equity grants aim to align management's interests with those of shareholders, potentially driving long-term value creation.
• Employees may be indirectly impacted by the company's performance against the FCF, ROIC, and TSR targets, which could influence overall compensation and job security.

Next Steps

• Continued monitoring of LivaNova PLC's performance against the FCF, ROIC, and TSR targets to determine the vesting of PSUs.
• Tracking of the stock price relative to the $39.13 exercise price of the SARs to assess their potential value.

Key Dates

Keywords

LivaNova PLC, Michael Damon Hutchinson, Chief Legal Officer, Form 4, Beneficial Ownership, Restricted Stock Units, Performance Stock Units, Stock Appreciation Rights, RSU, PSU, SAR, Vesting, Shares, Transactions